The role of ORC4 in enucleation of Murine Erythroleukemia (MEL) cells is similar to that in oocyte polar body extrusion.
DNA Replication
Murine Erythroleukemia cell (MEL)
ORC4
enucleation
erythroblast
extrusion
polar body
Journal
Systems biology in reproductive medicine
ISSN: 1939-6376
Titre abrégé: Syst Biol Reprod Med
Pays: England
ID NLM: 101464963
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
pubmed:
26
9
2020
medline:
30
9
2021
entrez:
25
9
2020
Statut:
ppublish
Résumé
The Origin Replication Complex subunit 4 (ORC4) is one in six subunits of the Origin Replication Complexes (ORCs) which is essential for initiating licensing at DNA replication origins and recruiting adaptor molecules necessary for various cellular processes. Previously, we reported that ORC4 also plays a vital role in polar body extrusion (PBE) during oogenesis in which half the chromosomes are extruded from the oocyte. We hypothesized that ORC4 might play a broader role in chromatin elimination. We tested its role in enucleation during the development of erythrocytes. Murine erythroleukemia (MEL) cells can be propagated in culture indefinitely and can be induced to enucleate their DNA by treatment with Vacuolin-1, thereby mimicking normal erythrocyte enucleation. We found that ORC4 appeared around the nuclei of the MEL cells with Vacuolin-1 treatment, gradually increasing in thickness before enucleation. We then tested whether ORC4 was required for MEL enucleation by down regulating ORC4 with siRNA-ORC4 during Vacuolin-1 treatment and found that this prevented MEL enucleation. These data are consistent with the model that ORC4 is required for erythroblast enucleation just as it is for oocyte PBE. They suggest a new model in which ORC4 expression is a marker for the initiation to the enucleation pathway.
Identifiants
pubmed: 32972244
doi: 10.1080/19396368.2020.1822458
pmc: PMC7704790
mid: NIHMS1632473
doi:
Substances chimiques
Heterocyclic Compounds, 4 or More Rings
0
Orc4 protein, mouse
0
Origin Recognition Complex
0
vacuolin-1
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
378-386Subventions
Organisme : NIGMS NIH HHS
ID : P30 GM131944
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM123048
Pays : United States
Références
J Cell Biochem. 2015 May;116(5):778-86
pubmed: 25502171
J Cell Biochem. 2017 Sep;118(9):2941-2949
pubmed: 28230328
Stem Cells Int. 2011;2011:139851
pubmed: 22007239
Nat Cell Biol. 2013 Aug;15(8):937-47
pubmed: 23873150
Front Physiol. 2018 Jul 11;9:829
pubmed: 30050448
Haematologica. 2012 Oct;97(10):1471-9
pubmed: 22491741
Trends Cell Biol. 2011 Jul;21(7):409-15
pubmed: 21592797
Arch Histol Jpn. 1982 Jul;45(3):247-55
pubmed: 7149915
Methods Mol Biol. 1991;7:421-34
pubmed: 21416373
Cell Death Differ. 2017 Nov;24(11):1845-1852
pubmed: 28841213
Cell. 2007 Aug 10;130(3):484-98
pubmed: 17693257
J Biol Chem. 2010 Dec 17;285(51):40252-65
pubmed: 20940306
Results Probl Cell Differ. 2012;55:23-44
pubmed: 22918799
Blood. 2010 Oct 28;116(17):3331-40
pubmed: 20644112
Curr Biol. 2008 Dec 23;18(24):1986-92
pubmed: 19062278
J Cell Biol. 1987 Dec;105(6 Pt 2):3105-18
pubmed: 2961771
Proc Natl Acad Sci U S A. 1974 Jul;71(7):2668-70
pubmed: 4527790
Cell. 2005 Oct 7;123(1):75-87
pubmed: 16213214
Curr Opin Hematol. 2014 May;21(3):165-71
pubmed: 24492678
J Cell Biol. 1982 May;93(2):390-4
pubmed: 6954153
Genes Dev. 2005 Dec 1;19(23):2827-36
pubmed: 16322558
Biophys Rev. 2019 Dec;11(6):873-894
pubmed: 31418139